SEC Form 4 · accession 0001209191-17-067474
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Roberts
Officer — President and Director · Director
Period of report
Dec 22, 2017
Accepted (ET)
Dec 27, 2017 · 8:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 22, 2017 | A | 1,997 | $0.00 | A | 26,479 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $31.30 | Dec 22, 2017 | A | 17,303 | A | Dec 22, 2017 | Dec 22, 2024 | Common Stock | 17,303 | 17,303 | D |
Explanation of responses
- F1Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
- F2This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.